Login to Your Account



House Members Grill FDA, ImClone On Approval Process

By Kim Coghill


Friday, October 11, 2002
WASHINGTON - The series of missteps surrounding the application process for ImClone Systems Inc.'s cancer drug, Erbitux, has forced the FDA to rethink some of its procedures. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription